# Virus-specific Activated T Lymphocytes From a Donor in Hematopoietic Progenitor Transplanted Patients

> **NCT04018261** · PHASE1,PHASE2 · COMPLETED · sponsor: **Banc de Sang i Teixits** · enrollment: 26 (actual)

## Conditions studied

- CMV Viremia
- Immunosuppression-related Infectious Disease

## Interventions

- **DRUG:** Activated T-Lymphocytes

## Key facts

- **NCT ID:** NCT04018261
- **Lead sponsor:** Banc de Sang i Teixits
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-04
- **Primary completion:** 2021-10-18
- **Final completion:** 2021-10-18
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2024-01-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04018261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04018261, "Virus-specific Activated T Lymphocytes From a Donor in Hematopoietic Progenitor Transplanted Patients". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04018261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*